Long Non-Coding RNA NEAT1 Promoted Hepatocellular Carcinoma Cell Proliferation and Reduced Apoptosis Through the Regulation of Let-7b-IGF-1R Axis

References

• Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020. doi:10.1002/hep.2419921374666
   PubMed Web of Science ®Google Scholar
• Han D, Li J, Wang H, et al. Circular RNA MTO1 acts as the sponge of miR-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017;66(4):1151. doi:10.1002/hep.2927028520103
   PubMed Web of Science ®Google Scholar
• Yong T, Jue R, Shiou-Hwei Y, et al. Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci U S A. 2011;108(29):12042–12047. doi:10.1073/pnas.110871510821730188
   PubMed Web of Science ®Google Scholar
• Balmain A. Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell. 2002;108(2):145–152. doi:10.1016/S0092-8674(02)00622-011832205
   PubMed Web of Science ®Google Scholar
• Nishiyama H, Takahashi T, Kakehi Y, et al. Homozygous deletion at the 9q32–33 candidate tumor suppressor locus in primary human bladder cancer. Genes Chromosomes Cancer. 2015;26(2):171–175. doi:10.1002/(SICI)1098-2264(199910)26:2<171::AID-GCC10>3.0.CO;2-B
   Google Scholar
• Hsieh HY, Jou YC, Tung CL, et al. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment. Oncogene. 2017;37(5):673–686.29035390
   PubMed Web of Science ®Google Scholar
• Reddy KB. MicroRNA (miRNA) in cancer. Cancer Cell Int. 2015;15(1):1–6. doi:10.1186/s12935-015-0185-125678856
   PubMedGoogle Scholar
• Luo JW, Wang X, Yang Y, et al. Role of micro-RNA (miRNA) in pathogenesis of glioblastoma. Eur Rev Med Pharmacol Sci. 2015;19(9):1630.26004603
   PubMed Web of Science ®Google Scholar
• Paydas S, Acikalin A, Ergin M, et al. Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables. Med Oncol. 2016;33(4):34. doi:10.1007/s12032-016-0749-526951445
   PubMed Web of Science ®Google Scholar
• Yanchun L, Hongmei Y, Zhihong C, et al. MicroRNA-192-5p promote the proliferation and metastasis of hepatocellular carcinoma cell by targeting SEMA3A. Appl Immunohistochem Mol Morphol. 2015;25(4):1.
   Google Scholar
• Hu S, Tao R, Wang S, et al. MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1. Tumor Biol. 2015;36(7):5467–5472. doi:10.1007/s13277-015-3213-9
   PubMedGoogle Scholar
• Chang RM, Yang H, Fang F, et al. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase. Hepatology. 2015;60(4):1251–1263. doi:10.1002/hep.27221
   Web of Science ®Google Scholar
• Yuan C, Liu C, Zou N. MicroRNA-340 targets NF-κB1 to inhibit cell proliferation, migration and invasion in hepatocellular carcinoma cell line. J Biomater Tissue Eng. 2016;6(8):649–658. doi:10.1166/jbt.2016.1481
   Web of Science ®Google Scholar
• Wang P, Cao J, Liu S, et al. Upregulated microRNA-429 inhibits the migration of HCC cells by targeting TRAF6 through the NF-κB pathway. Oncol Rep. 2017;37(5):2883. doi:10.3892/or.2017.550728440423
   PubMed Web of Science ®Google Scholar
• Plasterk RHA. RNA interference (RNAi). Encycl Entomol. 2008;7(5):3195–3196.
   Google Scholar
• Mansoori B, Sandoghchian SS, Baradaran B. RNA interference and its role in cancer therapy. Adv Pharm Bull. 2014;4(4):313–321. doi:10.5681/apb.2014.04625436185
   PubMedGoogle Scholar
• Zheng C, Chen Z, Bai E, et al. [Construction and identification of a lentiviral vector for RNA interference of human GLUT3 gene]. J Central South Uni. 2016;41(5):455–462.
   Google Scholar
• West JA, Davis CP, Sunwoo H, et al. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol Cell. 2014;55(5):791–802. doi:10.1016/j.molcel.2014.07.01225155612
   PubMed Web of Science ®Google Scholar
• Zhen L, Yun-Hui L, Hong-Yu D, et al. Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis. Tumour Biol. 2016;37(1):673. doi:10.1007/s13277-015-3843-y26242266
   PubMedGoogle Scholar
• Chai Y, Liu J, Zhang Z, et al. HuR‐regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer. Cancer Med. 2016;5(7):1588–1598. doi:10.1002/cam4.2016.5.issue-727075229
   PubMed Web of Science ®Google Scholar
• Qian K, Liu G, Tang Z, et al. The long non-coding RNA NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2. Arch Biochem Biophys. 2017;615:1. doi:10.1016/j.abb.2016.12.01128034643
   PubMed Web of Science ®Google Scholar
• Choudhry H, Albukhari A, Morotti M, et al. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene. 2015;34(34):4482–4490. doi:10.1038/onc.2014.37825417700
   PubMed Web of Science ®Google Scholar
• Zheng X, Zhang Y, Liu Y, et al. HIF‐2α activated lncRNA NEAT1 promotes hepatocellular carcinoma cell invasion and metastasis by affecting the epithelial‐mesenchymal transition. J Cell Biochem. 2018;119(4):3247–3256. doi:10.1002/jcb.v119.429091312
   PubMed Web of Science ®Google Scholar
• Jusufović E, Rijavec M, Keser D, et al. let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non–small–cell lung cancer. PLoS One. 2012;7(9):e45577. doi:10.1371/journal.pone.004557723029111
   PubMed Web of Science ®Google Scholar
• Huang Z, Gan J, Long Z, et al. Targeted delivery of let-7b to reprogramme tumor-associated macrophages and tumor infiltrating dendritic cells for tumor rejection. Biomaterials. 2016;90:72–84. doi:10.1016/j.biomaterials.2016.03.00926994345
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu K, Liu S, et al. MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma. Tumor Biol. 2015;36(12):9779–9788. doi:10.1007/s13277-015-3749-8
   PubMedGoogle Scholar
• Refolo MG, D’Alessandro R, Lippolis C, et al. IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines. Oncotarget. 2017;8(61):103465–103476. doi:10.18632/oncotarget.v8i6129262576
   PubMedGoogle Scholar
• Jean-Fran Ois D, Thierry D, Birgit W, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology. 2004;233(1):93. doi:10.1148/radiol.233103066015317953
   PubMed Web of Science ®Google Scholar
• Yao Y, Mao W, Dong M, et al. Serum Insulin-Like Growth Factor-1 (IGF-1): a novel prognostic factor for early recurrence of Hepatocellular Carcinoma (HCC). Clin Lab. 2017;63(2):261. doi:10.7754/Clin.Lab.2016.16073228182337
   PubMed Web of Science ®Google Scholar
• Jun T, Yang JD, Yeh ML, et al. 904 – significantly lower rates of cirrhosis and lower long-term survival in cryptogenic Hepatocellular Carcinoma (HCC) compared to viral etiologies: results of a multi-center international cohort. Gastroenterology. 2017;152(5):S1071. doi:10.1016/S0016-5085(17)33616-8
   Web of Science ®Google Scholar
• Chen X, Ren Z, Yin S, et al. The local liver ablation with pulsed electric field stimulate systemic immune reaction against hepatocellular carcinoma (HCC) with time-dependent cytokine profile. Cytokine. 2017;93:44–50. doi:10.1016/j.cyto.2017.05.00328506570
   PubMed Web of Science ®Google Scholar
• Bolondi L, Sofia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut. 2001;48(2):251–259. doi:10.1136/gut.48.2.25111156649
   PubMed Web of Science ®Google Scholar
• Kamimura K, Kobayashi Y, Takahashi Y, et al. Tumor markers for early diagnosis for brain metastasis of hepatocellular carcinoma: a case series and literature review for effective loco-regional treatment. Cancer Biol Ther. 2017;18(2):79–84. doi:10.1080/15384047.2016.127613428045618
   PubMed Web of Science ®Google Scholar
• Guo S, Chen W, Luo Y, et al. Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients. Int J Clin Exp Pathol. 2015;8(5):5395.26191242
   PubMed Web of Science ®Google Scholar
• Mang Y, Li L, Ran J, et al. Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells. Onco Targets Ther. 2017;10:1003–1016. doi:10.2147/OTT.S11631928260918
   PubMed Web of Science ®Google Scholar
• Han J, Zhang F, Yu M, et al. RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells. Cancer Lett. 2012;321(1):80–88. doi:10.1016/j.canlet.2012.02.02122381696
   PubMed Web of Science ®Google Scholar
• Pai SI, Lin YY, Macaes B, et al. Prospects of RNA interference therapy for cancer. Gene Ther. 2006;13(6):464–477. doi:10.1038/sj.gt.330269416341059
   PubMed Web of Science ®Google Scholar
• Wu S, Wang X, Chen JX, et al. Predictive factors for the sensitivity of radiotherapy and prognosis of esophageal squamous cell carcinoma. Int J Radiat Biol. 2014;90(5):407–413. doi:10.3109/09553002.2014.89464924576011
   PubMed Web of Science ®Google Scholar
• Yu J, Feng J, Zhi X, et al. Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer. Tumour Biol. 2015;36(5):3221–3229. doi:10.1007/s13277-014-2950-525510669
   PubMedGoogle Scholar
• Lu PW, Li L, Wang F, et al. Effects of long non-coding RNA HOST2 on cell migration and invasion by regulating MicroRNA Let-7b in breast cancer. J Cell Biochem. 2017;19(6):4570–4580.
   Google Scholar
• Han X, Wang X, Zhao B, et al. MicroRNA-187 inhibits tumor growth and metastasis via targeting of IGF-1R in hepatocellular carcinoma. Mol Med Rep. 2017;16(2):2241–2246. doi:10.3892/mmr.2017.678828627639
   PubMed Web of Science ®Google Scholar
• Rahmoon MA, Youness RA, Gomaa AI, et al. MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients. Growth Factors. 2017;35(2–3):1–12. doi:10.1080/08977194.2017.135485928264596
   PubMed Web of Science ®Google Scholar
• Chen CL, Wu JC, Chen GY, et al. Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis. Mol Ther. 2015;23(1):79–88. doi:10.1038/mt.2014.12625023326
   PubMed Web of Science ®Google Scholar